Search

everythinglearnresearchcommunity

for

Search:↓

Nafarelin may effectively treat excessive hair growth in women by reducing certain hormone levels.

Both finasteride and GnRH agonist treatments reduced hair growth in women with idiopathic hirsutism, but GnRH agonist was more effective.

The combination therapy reduced hirsutism in women with PCOD and was well-tolerated.

Removing both ovaries treated the woman's excess male hormone symptoms.

Hirsutism can be caused by various conditions besides PCOS, and it's important to treat the underlying issue and manage symptoms with medication and cosmetic approaches.

New treatments for excessive hair growth in women, including advanced drugs and nanotechnology, show promise for better results.

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.

Treating early puberty with hormone therapy may increase the risk of polycystic ovary syndrome in adults.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

GnRH analogues are effective for diagnosing and treating female androgen excess, offering a non-surgical option.

The research found that MRI and certain hormone levels can help tell apart ovarian tumors from hyperthecosis in postmenopausal women, but tissue analysis is still needed for a definite diagnosis.

The patient's high testosterone was reduced by a medication that suppresses gonadotropin.

Polycystic Ovary Syndrome likely starts in childhood and may be genetic and influenced by early hormone exposure.

Triptorelin helps evaluate hormone production in Sertoli-Leydig cell tumors.

Insulin resistance contributes to hormone imbalances in many women with polycystic ovary syndrome.

Hirsutism in women is often due to hormone sensitivity and has significant psychological effects.

The L457(3.43)R mutation in the human lutropin receptor causes increased activity and hormone insensitivity, leading to precocious puberty.

Non-invasive imaging helped diagnose a woman's severe hormone imbalance and diabetes, and medication successfully treated her condition.

The April 2014 issue of "Fertility and Sterility" discussed various reproductive health topics, including hormone therapy benefits, sperm and genetic factors in male infertility, and the link between PCOS and diabetes.

The study concluded that androstendione and DHEA are important for diagnosing high male hormone levels in women with excessive hair growth.

Doctors should know how to diagnose and treat PCOS, which often involves checking for high male hormone levels and using medications to manage symptoms.

Hirsutism is too much hair growth in women like the pattern in men, often caused by high male hormones, and can be treated with hormone control and hair removal methods.

Gender-affirming hormone therapy improves physical performance in trans men to the level of cisgender men, while in trans women, it increases fat mass and decreases muscle mass, with no advantage in physical performance after 2 years.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Women with androgenetic alopecia (hair loss) have normal prostate specific antigen levels but higher testosterone levels.

The hypothesis suggests that PCOS may start early in life due to genetic and environmental factors, influencing future reproductive and metabolic problems.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

A woman's severe male hormone excess was caused by a small, hard-to-find ovarian tumor.

More research is needed on the health effects of hormone therapy for transgender and nonbinary people.

A woman's rare ovarian tumor was treated with surgery, which stopped her symptoms and normalized her hormone levels.